Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anxiety Disorders

Trial Information

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder

Official Title: Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial

Summary

The purpose of this study is to evaluate the efficacy and safety of comparative high dose Tandospirone Citrate in the treatment of patients with generalized anxiety disorder.

Phase: Phase 4

Sponsor: Sumitomo Pharmaceutical (Suzhou) Co., Ltd.

Overall Contacts:

Wenyuan Wu, MD
86-21-66111487

Locations (1)

Country State City Zip Facility and Contact
China Shanghai 200065 Shanghai Tongji Hospital
Wenyuan Wu, MD

NCT ID:NCT01614041

Date Last Changed: February 19, 2013